| Atrial fibrillation : New anticoagulants and antiarrhythmic drugs. | |
| | |
MedLine Citation:
|
PMID: 22382136 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Atrial fibrillation is the most common form of arrhythmia and one of the most frequent causes of ischemic stroke. Several new anticoagulants have recently been introduced as alternatives to vitamin-K antagonists for prophylaxis of ischemic stroke and tested in phase-3 studies for efficacy and safety. Identifying patients who will profit in particular from the new anticoagulant therapy is crucial to the clinical application of these drugs. Vernakalant and dronedarone are new antiarrhythmic drugs for rhythm control of atrial fibrillation. However, therapeutic efficacy of the new agents still has to be proven. |
| | |
Authors:
|
E Kaya; G Frommeyer; G Mönnig; L Eckardt |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-3-2 |
Journal Detail:
|
Title: Herz Volume: - ISSN: 1615-6692 ISO Abbreviation: - Publication Date: 2012 Mar |
Date Detail:
|
Created Date: 2012-3-2 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7801231 Medline TA: Herz Country: - |
Other Details:
|
Languages: GER Pagination: - Citation Subset: - |
Affiliation:
|
Abteilung für Rhythmologie, Department für Kardiologie und Angiologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Gebäude A1, 48149, Münster, Deutschland, elif.kaya@ukmuenster.de. |
Vernacular Title:
|
Vorhofflimmern : Neue Antiarrhythmika und Antikoagulanzien. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Decreased c-Jun expression correlates with impaired spinal motoneuron regeneration in aged mice foll...
Next Document: Interventional electrophysiology in cardiac MRI : What is the current status?